These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8376824)

  • 1. Diagnosis of Lyme disease should be made on clinical grounds.
    Berman DS; Wenglin BD
    J Infect Dis; 1993 Oct; 168(4):1073. PubMed ID: 8376824
    [No Abstract]   [Full Text] [Related]  

  • 2. Intralaboratory reliability of serologic and urine testing for Lyme disease.
    Klempner MS; Schmid CH; Hu L; Steere AC; Johnson G; McCloud B; Noring R; Weinstein A
    Am J Med; 2001 Feb; 110(3):217-9. PubMed ID: 11182109
    [No Abstract]   [Full Text] [Related]  

  • 3. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area.
    Nyman D; Willén L; Jansson C; Carlsson SA; Granlund H; Wahlberg P
    Clin Microbiol Infect; 2006 May; 12(5):496-7. PubMed ID: 16643532
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial commentary: laboratory testing for Lyme disease: time for a change?
    Weinstein A
    Clin Infect Dis; 2008 Jul; 47(2):196-7. PubMed ID: 18532894
    [No Abstract]   [Full Text] [Related]  

  • 5. More specific bands in the IgG western blot in sera from Scottish patients with suspected Lyme borreliosis.
    Evans R; Mavin S; McDonagh S; Chatterton JM; Milner R; Ho-Yen DO
    J Clin Pathol; 2010 Aug; 63(8):719-21. PubMed ID: 20595179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lyme's serology].
    Armand-Lefevre L
    Ann Dermatol Venereol; 2003 Mar; 130(3):385-7. PubMed ID: 12746682
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant or peptide antigens in the serology of Lyme arthritis in children.
    Heikkilä T; Huppertz HI; Seppälä I; Sillanpää H; Saxen H; Lahdenne P
    J Infect Dis; 2003 Jun; 187(12):1888-94. PubMed ID: 12792865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Actual diagnostic possibilities of Lyme borreliosis].
    Hermanowska-Szpakowicz T; Swierzbińska R; Zajkowska JM; Izycka-Herman A; Pancewicz SA; Kondrusik M
    Pol Merkur Lekarski; 2000 Jan; 7(43):69-71. PubMed ID: 10765660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serodiagnosis of Lyme borreliosis using detection of different immunoglobulin (sub)classes by enzyme-linked immunosorbent assay and Western blotting.
    Goossens HA; van den Bogaard AE; Nohlmans MK
    Clin Lab; 2001; 47(1-2):41-9. PubMed ID: 11214222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Western-blot with VLSE protein and "in vivo" antigens in Lyme borreliosis diagnosis].
    Zajkowska J; Kondrusik M; Pancewicz S; Grygorczuk S; Swierzbińska R; Hermanowska-Szpakowicz T; Czeczuga A; Sienkiewicz I
    Przegl Epidemiol; 2006; 60 Suppl 1():177-85. PubMed ID: 16909799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test.
    Branda JA; Aguero-Rosenfeld ME; Ferraro MJ; Johnson BJ; Wormser GP; Steere AC
    Clin Infect Dis; 2010 Jan; 50(1):20-6. PubMed ID: 19947857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
    Dickeson DJ; Chen SC; Sintchenko VG
    Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
    Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
    Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of the 3M Fast-Lyme test in the early diagnosis of borreliosis].
    Borowska SC; Szymański W; Rogalewska A; Michalska I; Kowal K
    Pneumonol Alergol Pol; 1991; 59 Suppl 1():65-8. PubMed ID: 1843813
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and serological features of patients with suspected Lyme borreliosis.
    Santino I; Longobardi V
    Int J Immunopathol Pharmacol; 2011; 24(3):797-801. PubMed ID: 21978712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of western blot and enzyme-linked immunosorbent assays to assist in the diagnosis of Lyme disease.
    Rose CD; Fawcett PT; Singsen BH; Dubbs SB; Doughty RA
    Pediatrics; 1991 Sep; 88(3):465-70. PubMed ID: 1881724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of surface immunofluorescence assay (SIFA) in the microbiological diagnosis of Lyme borreliosis: a case report.
    Sambri V; Armati S; D'Apote L; Farencena A; Marangoni A; Massaria F; Moroni A; Cevenini R
    New Microbiol; 1995 Jul; 18(3):307-10. PubMed ID: 7553367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of lyme borreliosis in europe.
    Wilske B
    Vector Borne Zoonotic Dis; 2003; 3(4):215-27. PubMed ID: 14733674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between early and late complicated Lyme borreliosis by specific IgG avidity.
    Guérineau AL; Dhôte R; Christiann F; Rayet P; Assous MV
    Lancet; 1999 Sep; 354(9184):1096-7. PubMed ID: 10509507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of Lyme disease].
    Otani S
    Nihon Rinsho; 1990 Feb; 48 Suppl():430-3. PubMed ID: 2192136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.